Keywords: medimmune, new, flu, vacc, performs, well, drugmaker

MedImmune's new flu vacc performs well

Article | 27 June 2005

Print This

US drugmaker MedImmune says that the primary objective of a Phase III trial assessing the immunogenicity of two different formulations ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in